Skip Ribbon Commands
Skip to main content

Gastrointestinal

Colon

  • CTSU C80702: A Phase III Trial of 6 versus 12 treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for patients with Resected Stage III Colon Cancer

Esophageal/GE Junction

  • SWOG S1201: Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer

Pancreas

  • SWOG 1115​: Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate and MK-2206 vs mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133​​.​​​​​

 
 [+/−]  Feedback